[
    [
        {
            "time": "",
            "original_text": "港股收评：恒生科技指大涨3.4%，科技、医药板块集体爆发",
            "features": {
                "keywords": [
                    "恒生科技指",
                    "大涨",
                    "科技",
                    "医药",
                    "板块",
                    "爆发"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "科技",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股收评：恒生科技指大涨3.4%，科技、医药板块集体爆发",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 10,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "股价大跌40%，商誉超90亿，民营医药巨头的“捷径”还能走多远？ 连续下跌",
            "features": {
                "keywords": [
                    "股价大跌",
                    "商誉",
                    "民营医药",
                    "巨头",
                    "捷径",
                    "连续下跌"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "股价大跌40%，商誉超90亿，民营医药巨头的“捷径”还能走多远？ 连续下跌",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "发现丙肝病毒，3名科学家获得诺贝尔奖！这些概念股或受关注",
            "features": {
                "keywords": [
                    "丙肝病毒",
                    "诺贝尔奖",
                    "科学家",
                    "概念股",
                    "关注"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "发现丙肝病毒，3名科学家获得诺贝尔奖！这些概念股或受关注",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]